New Data Show Incidence of Drowsiness and Sedation is Higher for Some Patients Taking Xyzal(R) (Levocetirizine) Than Patients Prescribed AERIUS(R) [NEOCLARITYN(R)] (Desloratadine) Within one Month of Treatment
Some patients taking Xyzal (levocetirizine) are more likely to experiencedrowsiness and sedation within one month of treatment than patientsprescribed AERIUS [NEOCLARITYN] (desloratadine), according to data publishedin the October issue of Drug Safety.(1)
The observational are al world’ study utilizing the Prescription EventMonitoring (PEM) system conducted by Drug Safety Research Unit (DSRU), anindependent research group affiliated with […]